ATA204083A - Verfahren zur herstellung von neuen, in 2-stellung substituierten derivaten der 4-hydroxy-3- chinolin-carbonsaeure - Google Patents

Verfahren zur herstellung von neuen, in 2-stellung substituierten derivaten der 4-hydroxy-3- chinolin-carbonsaeure

Info

Publication number
ATA204083A
ATA204083A AT0204083A AT204083A ATA204083A AT A204083 A ATA204083 A AT A204083A AT 0204083 A AT0204083 A AT 0204083A AT 204083 A AT204083 A AT 204083A AT A204083 A ATA204083 A AT A204083A
Authority
AT
Austria
Prior art keywords
hydroxy
production
carbonic acid
acid substituted
new derivatives
Prior art date
Application number
AT0204083A
Other languages
English (en)
Other versions
AT385034B (de
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ATA204083A publication Critical patent/ATA204083A/de
Application granted granted Critical
Publication of AT385034B publication Critical patent/AT385034B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
AT0204083A 1982-06-03 1983-06-03 Verfahren zur herstellung von neuen, in 2-stellung substituierten derivaten der 4-hydroxy-3- chinolin-carbonsaeure AT385034B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8209654A FR2530633A1 (fr) 1982-06-03 1982-06-03 Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant

Publications (2)

Publication Number Publication Date
ATA204083A true ATA204083A (de) 1987-07-15
AT385034B AT385034B (de) 1988-02-10

Family

ID=9274589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0204083A AT385034B (de) 1982-06-03 1983-06-03 Verfahren zur herstellung von neuen, in 2-stellung substituierten derivaten der 4-hydroxy-3- chinolin-carbonsaeure

Country Status (13)

Country Link
US (3) US4486438A (de)
JP (1) JPS58225066A (de)
AT (1) AT385034B (de)
BE (1) BE896941A (de)
CA (1) CA1204116A (de)
CH (2) CH659469A5 (de)
DE (1) DE3320102A1 (de)
FR (1) FR2530633A1 (de)
GB (1) GB2123817B (de)
IT (1) IT1174760B (de)
LU (1) LU84841A1 (de)
NL (1) NL8301963A (de)
SE (2) SE461041B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553769B1 (fr) * 1983-10-20 1986-03-14 Roussel Uclaf Nouveau procede de preparation de derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2
FR2564835B1 (fr) * 1984-05-23 1986-10-24 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par un groupement soufre, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
US4845105A (en) * 1984-10-30 1989-07-04 Roussel Uclaf 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
FR2585356B1 (fr) * 1985-07-25 1987-10-23 Roussel Uclaf Nouveaux derives de l'acide 4-oh quinoleine carboxylique substitues en 2 par deux fonctions hydroxyle eventuellement etherifiees ou esterifiees, leurs procedes de preparation, les nouveaux intermediaires obtenus, leur application comme medicaments et les compositions les renfermant
FR2572404B2 (fr) * 1984-10-30 1987-12-11 Roussel Uclaf Nouveaux derives de l'acide 4-oh-3-quinoleine carboxylique substitues en 2, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
JPH04503820A (ja) * 1989-12-04 1992-07-09 ウラルスキ ポリテフニチェスキ インスティテュト イメニ エス.エム.キロバ 縮合されたテトラヒドロキノキサリンのカルボン酸のボルニル及びイソボルニルエステル
GT200600180A (es) * 2005-04-29 2006-11-22 Proceso para preparar isatinas con control de formacion de subproductos
US9139529B2 (en) * 2013-01-31 2015-09-22 Vertex Pharmaceuticals Incorporated Substituted quinoxalines as sodium channel modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB610619A (en) * 1945-05-17 1948-10-19 Rhone Poulenc Sa Process for the separation of isomeric substituted quinoline carboxylic acids and esters thereof
GB1007331A (en) * 1960-12-01 1965-10-13 Fisons Pest Control Ltd Quinazolin-3-oxides and benzo-1,2,3-triazine-3-oxides
US3491138A (en) * 1964-06-26 1970-01-20 American Home Prod Benzodiazepine intermediates
FR2340735A1 (fr) * 1976-02-11 1977-09-09 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2482596A1 (fr) * 1980-05-19 1981-11-20 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
GB2123817B (en) 1985-09-04
SE8703886L (sv) 1987-10-08
GB8315132D0 (en) 1983-07-06
BE896941A (fr) 1983-12-02
IT1174760B (it) 1987-07-01
US4736033A (en) 1988-04-05
CA1204116A (fr) 1986-05-06
FR2530633B1 (de) 1984-12-28
SE8703886D0 (sv) 1987-10-08
CH659818A5 (fr) 1987-02-27
CH659469A5 (fr) 1987-01-30
JPH0354658B2 (de) 1991-08-20
SE8302474D0 (sv) 1983-05-02
GB2123817A (en) 1984-02-08
FR2530633A1 (fr) 1984-01-27
AT385034B (de) 1988-02-10
SE8302474L (sv) 1983-12-04
US4596875A (en) 1986-06-24
NL8301963A (nl) 1984-01-02
LU84841A1 (fr) 1984-03-07
JPS58225066A (ja) 1983-12-27
SE466656B (sv) 1992-03-16
US4486438A (en) 1984-12-04
SE461041B (sv) 1989-12-18
DE3320102A1 (de) 1983-12-08
DE3320102C2 (de) 1992-07-02

Similar Documents

Publication Publication Date Title
AT378768B (de) Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten
AT382150B (de) Verfahren zur herstellung von neuen 3-amino-2-oxo-azetidin-1-sulfonsaeurederivaten
AT385755B (de) Verfahren zur herstellung von neuen pyrensulfonsaeurederivaten
AT376654B (de) Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten
AT385034B (de) Verfahren zur herstellung von neuen, in 2-stellung substituierten derivaten der 4-hydroxy-3- chinolin-carbonsaeure
AT385035B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT379388B (de) Verfahren zur herstellung von neuen 4-chinolonderivaten
AT375917B (de) Verfahren zur herstellung von harnstoffkoernern
ATA271583A (de) Verfahren zur herstellung von neuen lh-fshreleasingfaktoranaloga
AT375076B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT371469B (de) Verfahren zur herstellung von neuen penamcarbonsaeure-derivaten
AT380248B (de) Verfahren zur herstellung von neuen dithiolanderivaten
ATA230583A (de) Verfahren zur herstellung von neuen saeurederivaten
AT373891B (de) Verfahren zur herstellung von neuen rifamycinderivaten
AT374451B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT377975B (de) Verfahren zur herstellung von neuen nitrilotriessigsaeureamiden
AT378179B (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-prostaglandinderivaten
AT381940B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT377976B (de) Verfahren zur herstellung von neuen 16-amino-prostaglandinderivaten
AT376419B (de) Verfahren zur herstellung von neuen n-geschuetzten 4-oxo-azetidin-2-carbonsaeurederivaten
AT373890B (de) Verfahren zur herstellung von neuen 1,4;3,6-dianhydro-2,5-diazido-2,5-didesoxy-hexit-derivaten
ATA351081A (de) Verfahren zur herstellung von neuen cephalosporan-saeurederivaten
ATA46086A (de) Verfahren zur herstellung von neuen 2-thiacephemderivaten
ATA76288A (de) Verfahren zur herstellung von neuen mitosan-derivaten
ATA904183A (de) Verfahren zur herstellung von neuen desoxyuridinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification